GlassScriptPhysician profile
Renee Alexis
NPI 1780775726
$1,121.45
in general payments reported to CMS, 2019-2025
16 companies · $83.40 in 2025
The $83.40 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $141 · 2021: $370 · 2022: $114 · 2023: $101 · 2024: $17.17 · 2025: $83.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $554.27 | 2019-2023 | Orilissa |
| Myovant Sciences INC. | $145.53 | 2021-2022 | |
| Avion Pharmaceuticals | $54.89 | 2019-2021 | |
| Roche Diagnostics Corporation | $47.98 | 2019 | |
| Hologic Sales and Service, LLC | $46.34 | 2019 | |
| Sumitomo Pharma America, INC. | $35.32 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $35.22 | 2022 | |
| Ethicon US, LLC | $30.97 | 2023 | Stratafix, Dermabond Prineo |
| Exeltis, USA INC. | $30.86 | 2022-2025 | Slynd |
| Heron Therapeutics, INC. | $29.17 | 2023 | Zynrelef |
| Gilead Sciences, INC. | $28.36 | 2025 | |
| Lilly USA, LLC | $23.00 | 2025 | Zepbound |
| Biogen, INC. | $16.45 | 2025 | Zurzuvae |
| Allergan, INC. | $16.25 | 2020 | |
| Coopersurgical, INC. | $15.62 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Alexis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.